Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B or C virus coinfection: the data collection on adverse events of anti-HIV drugs study
about
Hepatitis C: Treatment of difficult to treat patientsHepatitis C in human immunodeficiency virus co-infected individuals: Is this still a "special population"?Antiretroviral Drugs and Risk of Chronic Alanine Aminotransferase Elevation in Human Immunodeficiency Virus (HIV)-Monoinfected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study.Noncommunicable diseases in HIV infection in low- and middle-income countries: gastrointestinal, hepatic, and nutritional aspects.Key toxicity issues with the WHO-recommended first-line antiretroviral therapy regimen.Nonalcoholic Steatohepatitis and Hepatic Fibrosis in HIV-1-Monoinfected Adults With Elevated Aminotransferase Levels on Antiretroviral Therapy.Strong Impact of Smoking on Multimorbidity and Cardiovascular Risk Among Human Immunodeficiency Virus-Infected Individuals in Comparison With the General PopulationAIDS and HIV Infection after Thirty Years.Methylome-wide Analysis of Chronic HIV Infection Reveals Five-Year Increase in Biological Age and Epigenetic Targeting of HLA.Critical care of persons infected with the human immunodeficiency virus.Serious Non-AIDS events: Immunopathogenesis and interventional strategies.Liver involvement in human immunodeficiency virus infection.Brief Report: Factors Associated With the Selection of Initial Antiretroviral Therapy From 2009 to 2012.A new trend of genotype distribution of hepatitis B virus infection in southeast China (Fujian), 2006-2013.A Review of Long-Term Toxicity of Antiretroviral Treatment Regimens and Implications for an Aging Population.
P2860
Q26798465-AA9D4686-C51C-4E31-ACEC-DF629BCDF2B9Q26798469-D8643E02-127E-40A8-82ED-5B095CFF8397Q31050092-7C08A107-8C2A-4ED2-9E26-1FEADF646545Q34157953-7D9D43BF-072E-446D-B54D-1459BC7825BFQ34536677-1EC433AF-D407-4130-9728-C39382CBB9EDQ35588143-7E0D6E6C-98D7-49D5-87A7-528E75FBCA60Q35748552-233031F9-F8C3-4FD0-B030-97DF3DD65607Q36566120-9EE06273-7F64-458D-8F9E-5788E9C3A365Q37198065-232609A7-D112-4265-8AC4-3C01472C6D0FQ37205963-21117EBD-6004-425D-888E-D1DBD583EAEFQ37418140-10E2458E-5D87-4FEF-B21F-6C5EB4803ACCQ38852184-76FAF522-5ADE-4009-89B3-8BFAB3821E60Q40566267-573125B3-37C1-4672-9004-B3BFBFB28687Q41484635-A2F4811F-AA02-4E74-9324-DA16ED002B4FQ54211761-F6EB76D9-DD40-4A64-8036-5468666355B3
P2860
Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B or C virus coinfection: the data collection on adverse events of anti-HIV drugs study
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Antiretroviral drug-related li ...... events of anti-HIV drugs study
@ast
Antiretroviral drug-related li ...... events of anti-HIV drugs study
@en
type
label
Antiretroviral drug-related li ...... events of anti-HIV drugs study
@ast
Antiretroviral drug-related li ...... events of anti-HIV drugs study
@en
prefLabel
Antiretroviral drug-related li ...... events of anti-HIV drugs study
@ast
Antiretroviral drug-related li ...... events of anti-HIV drugs study
@en
P2093
P2860
P50
P356
P1476
Antiretroviral drug-related li ...... events of anti-HIV drugs study
@en
P2093
Andrew Phillips
Bruno Ledergerber
Colette Smith
Eric Fontas
Helen Kovari
Kathy Petoumenos
Peter Reiss
Philippe Morlat
Rainer Weber
P2860
P304
P356
10.1093/CID/CIS919
P407
P577
2012-10-22T00:00:00Z